The agreement was signed during a side event at the 30th IAEA Fusion Energy Conference in Chengdu, China, last week.
China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation (CNNC) and the MoU signed with the National Nuclear Energy Commission (CNEN) covers an initial three year period during which they will “deepen studies on technical and commercial feasibility, based on sustainable business models and in accordance with the legislation of both countries”.
CNEN said the agreement does not involve the transfer of financial resources but “reflects the commitment of the two nations to guarantee access to nuclear inputs indispensable for medicine, industry and research, strengthening the security of supply of these strategic materials”.
It added: “Among the materials contemplated are iodine-131, lutetium-177, molybdenum-99, cobalt-60, carbon-14 and iridium-192, in addition to other radioisotopes applied in health, industrial production and scientific research. Promoting access to these elements means contributing to advances in health, more effective treatments, and scientific innovation with a direct impact on society.
“The memorandum between Brazil and China translates, in a single gesture, the greater purpose of nuclear cooperation: to put science at the service of life.”
